Dr Keith Martin, the chief executive of Chepstow-based clinical biotech company Apitope, is to retire from the company. Insider Media reports Apitope, who develop antigen-specific immunotherapies targeting autoimmune diseases, revealed Keith Martin had decided to retire after twelve years. Keith Martin will remain on the Apitope Board as a non-executive director. Dr Hayley French will … Continue reading Chief executive retires from Apitope